1-9 of 9
Thomas Forst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial

Jort Kropff, Pratik Choudhary, Sankalpa Neupane, Katharine Barnard, Steve C. Bain, Christoph Kapitza, Thomas Forst, Manuela Link, Andrew Dehennis, J. Hans DeVries
Journal: Diabetes Care
Diabetes Care 2017;40(1):63–68
https://doi.org/10.2337/dc16-1525
Published: 04 November 2016
View article titled, Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial
Open the PDF for Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial in another window
Includes: Supplementary data
Journal Articles

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial

Juris J. Meier, Julio Rosenstock, Agnès Hincelin-Méry, Christine Roy-Duval, Astrid Delfolie, Hans-Veit Coester, Bjoern A. Menge, Thomas Forst, Christoph Kapitza
Journal: Diabetes Care
Diabetes Care 2015;38(7):1263–1273
https://doi.org/10.2337/dc14-1984
Published: 17 April 2015
View article titled, Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial
Open the PDF for Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial in another window
Includes: Supplementary data
Journal Articles

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

Matthew C. Riddle, MD, Thomas Forst, MD, Ronnie Aronson, MD, Leobardo Sauque-Reyna, MD, Elisabeth Souhami, MD, Louise Silvestre, MD, Lin Ping, MD, Julio Rosenstock, MD
Journal: Diabetes Care
Diabetes Care 2013;36(9):2497–2503
https://doi.org/10.2337/dc12-2462
Published: 13 August 2013
View article titled, Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: <subtitle>A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)</subtitle>
Open the PDF for Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: <subtitle>A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)</subtitle> in another window
Includes: Supplementary data
Journal Articles

Postprandial Vascular Effects of VIAject Compared With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes

Thomas Forst, MD, Andreas Pfützner, MD, PHD, Frank Flacke, PHD, Alan Krasner, MD, Cloth Hohberg, MD, Eda Tarakci, Philip Pichotta, PHD, Senait Forst, Solomon Steiner, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(1):116–120
https://doi.org/10.2337/dc09-0411
Published: 06 October 2009
View article titled, Postprandial Vascular Effects of VIAject Compared With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes
Open the PDF for Postprandial Vascular Effects of VIAject Compared With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes in another window
Journal Articles

Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State

Clothilde Hohberg, MD, Thomas Forst, MD, Martin Larbig, PHD, Michael Safinowski, PHD, Stefan Diessel, MD, Silvia Hehenwarter, Matthias M. Weber, MD, Thomas Schöndorf, PHD, Andreas Pfützner, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(5):1021–1025
https://doi.org/10.2337/dc07-2185
Published: 01 May 2008
View article titled, Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State
Open the PDF for Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State in another window
Journal Articles

Development and Validation of a New Measure to Evaluate Psychological Resistance to Insulin Treatment

Frank Petrak, PHD, Elmar Stridde, MD, Friedhelm Leverkus, Alexander A. Crispin, MD, Thomas Forst, MD, Andreas Pfützner, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(9):2199–2204
https://doi.org/10.2337/dc06-2042
Published: 01 September 2007
View article titled, Development and Validation of a New Measure to Evaluate Psychological Resistance to Insulin Treatment
Open the PDF for Development and Validation of a New Measure to Evaluate Psychological Resistance to Insulin Treatment in another window
Includes: Supplementary data
Journal Articles

Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes

Andreas Pfützner, MD, PHD, Thomas Kunt, MD, Cloth Hohberg, MD, Agnes Mondok, MD, Sabine Pahler, MSC, Thomas Konrad, MD, Georg Lübben, MD, Thomas Forst, MD
Journal: Diabetes Care
Diabetes Care 2004;27(3):682–687
https://doi.org/10.2337/diacare.27.3.682
Published: 01 March 2004
View article titled, Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes
Open the PDF for Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes in another window
Journal Articles

Effect of C-Peptide on Glucose Metabolism in Patients With Type 1 Diabetes

Thomas Forst, Klaus Rave, Andreas Pfuetzner, Ronald Buchholz, Thomas Pohlmann, Mirjam Löbig, Lutz Heinemann
Journal: Diabetes Care
Diabetes Care 2002;25(6):1096–1097
https://doi.org/10.2337/diacare.25.6.1096
Published: 01 June 2002
View article titled, Effect of C-Peptide on Glucose Metabolism in Patients With Type 1 Diabetes
Open the PDF for Effect of C-Peptide on Glucose Metabolism in Patients With Type 1 Diabetes in another window
Journal Articles

Response to Jungheim and Koschinsky

Andreas Pfützner, MD, PHD, Thomas Forst, MD
Journal: Diabetes Care
Diabetes Care 2002;25(3):638–639
https://doi.org/10.2337/diacare.25.3.638
Published: 01 March 2002
View article titled, Response to Jungheim and Koschinsky
Open the PDF for Response to Jungheim and Koschinsky in another window